Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).
Blasi
F
F
Institute of Respiratory Diseases, University of Milan, IRCCS Ospedale Maggiore di Milano, Italy. francesco.blasi@unimi.it
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D001991:Bronchitis / Q000188:drug therapy / Q000382:microbiology; D002908:Chronic Disease; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D024841:Fluoroquinolones / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D064704:Levofloxacin; D008297:Male; D015242:Ofloxacin / Q000008:administration & dosage*; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000382:microbiology; D016032:Randomized Controlled Trials as Topic; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D064704:Levofloxacin; D015242:Ofloxacin